New hope in myeloma: can adding daratumumab improve standard therapy?
NCT ID NCT04268498
First seen Apr 01, 2026 · Last updated May 21, 2026 · Updated 6 times
Summary
This study compares two drug combinations for people newly diagnosed with multiple myeloma, a type of blood cancer. About 310 participants will receive either a standard three-drug regimen (carfilzomib, lenalidomide, dexamethasone) or that same regimen plus daratumumab. The goal is to see which approach is safer and better at reducing cancer cells to very low levels.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Huntsman Cancer Institue
Salt Lake City, Utah, 84113, United States
-
MD Anderson Cancer Center
Houston, Texas, 77030, United States
-
Memorial Sloan Kettering Cancer Center
New York, New York, 10065, United States
-
Moffitt Cancer Center
Tampa, Florida, 33612-9497, United States
-
Roswell Park Comprehensive Cancer Center
Buffalo, New York, 14203, United States
-
Stony Brook University
Stony Brook, New York, 11794, United States
-
University of Miami
Miami, Florida, 33136, United States
Conditions
Explore the condition pages connected to this study.